<DOC>
	<DOCNO>NCT01366339</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled , phase I study normal healthy volunteer . Study treatment include single dos MNTX placebo . In addition , half active treatment group randomize second , replicate dose MNTX , placebo group receive additional placebo dose .</brief_summary>
	<brief_title>Tolerance Pharmacokinetics Study MNTX Tablets</brief_title>
	<detailed_description />
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>1 . Weight 55 85 kg 2 . In good health evidence clinically significant chronic medical condition 3 . NonSmokers . 1 . History asthma , allergic skin rash , significant allergy immunologic disorder 2 . Known suspected hypersensitivity opioids opioid antagonists 3 . History suspicion alcohol drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>